ID ENTP1_RAT Reviewed; 511 AA. AC P97687; DT 20-JUN-2001, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-1997, sequence version 1. DT 27-MAR-2024, entry version 138. DE RecName: Full=Ectonucleoside triphosphate diphosphohydrolase 1 {ECO:0000305}; DE EC=3.6.1.5 {ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, ECO:0000269|PubMed:9364474}; DE AltName: Full=ATP diphosphohydrolase {ECO:0000250|UniProtKB:P49961}; DE Short=ATP-DPH {ECO:0000250|UniProtKB:P49961}; DE Short=ATPDase {ECO:0000250|UniProtKB:P49961}; DE AltName: Full=Ecto-ATP diphosphohydrolase 1 {ECO:0000250|UniProtKB:P49961}; DE Short=Ecto-ATPDase 1; DE Short=Ecto-ATPase 1; DE AltName: Full=Ecto-apyrase {ECO:0000303|PubMed:9221928}; DE AltName: Full=Lymphoid cell activation antigen {ECO:0000250|UniProtKB:P49961}; DE AltName: Full=Nucleoside triphosphate diphosphohydrolase 1 {ECO:0000303|PubMed:22100451}; DE Short=NTPDase1 {ECO:0000303|PubMed:22100451}; DE AltName: CD_antigen=CD39 {ECO:0000303|PubMed:9221928}; GN Name=Entpd1 {ECO:0000312|RGD:69265}; GN Synonyms=Cd39 {ECO:0000303|PubMed:9221928}; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, FUNCTION, COFACTOR, RP GLYCOSYLATION, AND TISSUE SPECIFICITY. RC STRAIN=Sprague-Dawley; TISSUE=Brain, and Hippocampus; RX PubMed=9221928; DOI=10.1016/s0169-328x(97)00066-1; RA Wang T.-F., Rosenberg P.A., Guidotti G.; RT "Characterization of brain ecto-apyrase: evidence for only one ecto-apyrase RT (CD39) gene."; RL Brain Res. Mol. Brain Res. 47:295-302(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] OF 432-511, FUNCTION, AND CATALYTIC ACTIVITY. RC STRAIN=Sprague-Dawley; TISSUE=Brain; RX PubMed=9364474; DOI=10.1016/s0028-3908(97)00115-9; RA Kegel B., Braun N., Heine P., Maliszewski C.R., Zimmermann H.; RT "An ecto-ATPase and an ecto-ATP diphosphohydrolase are expressed in rat RT brain."; RL Neuropharmacology 36:1189-1200(1997). RN [3] {ECO:0007744|PDB:3ZX0, ECO:0007744|PDB:3ZX2, ECO:0007744|PDB:3ZX3} RP X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 38-477, DISULFIDE BONDS, FUNCTION, RP CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=22100451; DOI=10.1016/j.jmb.2011.10.050; RA Zebisch M., Krauss M., Schafer P., Strater N.; RT "Crystallographic evidence for a domain motion in rat nucleoside RT triphosphate diphosphohydrolase (NTPDase) 1."; RL J. Mol. Biol. 415:288-306(2012). CC -!- FUNCTION: Catalyzes the hydrolysis of both di- and triphosphate CC nucleotides (NDPs and NTPs) and hydrolyze NTPs to nucleotide CC monophosphates (NMPs) in two distinct successive phosphate-releasing CC steps, with NDPs as intermediates and participates in the regulation of CC extracellular levels of nucleotides (PubMed:9221928, PubMed:9364474, CC PubMed:22100451). By hydrolyzing proinflammatory ATP and platelet- CC activating ADP to AMP, it blocks platelet aggregation and supports CC blood flow (By similarity). {ECO:0000250|UniProtKB:P49961, CC ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a ribonucleoside 5'-triphosphate + 2 H2O = a ribonucleoside CC 5'-phosphate + 2 H(+) + 2 phosphate; Xref=Rhea:RHEA:36795, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:58043, ChEBI:CHEBI:61557; EC=3.6.1.5; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36796; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'- CC diphosphate + H(+) + phosphate; Xref=Rhea:RHEA:23680, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57930, ChEBI:CHEBI:61557; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23681; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC -!- CATALYTIC ACTIVITY: CC Reaction=a ribonucleoside 5'-diphosphate + H2O = a ribonucleoside 5'- CC phosphate + H(+) + phosphate; Xref=Rhea:RHEA:36799, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57930, ChEBI:CHEBI:58043; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36800; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + 2 H2O = AMP + 2 H(+) + 2 phosphate; CC Xref=Rhea:RHEA:20988, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456215; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20989; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13066; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC -!- CATALYTIC ACTIVITY: CC Reaction=ADP + H2O = AMP + H(+) + phosphate; Xref=Rhea:RHEA:61436, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:456215, ChEBI:CHEBI:456216; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61437; CC Evidence={ECO:0000269|PubMed:22100451, ECO:0000269|PubMed:9221928, CC ECO:0000269|PubMed:9364474}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CTP + 2 H2O = CMP + 2 H(+) + 2 phosphate; CC Xref=Rhea:RHEA:64908, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:37563, ChEBI:CHEBI:43474, ChEBI:CHEBI:60377; CC Evidence={ECO:0000250|UniProtKB:P49961}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64909; CC Evidence={ECO:0000250|UniProtKB:P49961}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CTP + H2O = CDP + H(+) + phosphate; Xref=Rhea:RHEA:29387, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37563, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:58069; CC Evidence={ECO:0000250|UniProtKB:P49961}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29388; CC Evidence={ECO:0000250|UniProtKB:P49961}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CDP + H2O = CMP + H(+) + phosphate; Xref=Rhea:RHEA:64880, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:58069, ChEBI:CHEBI:60377; CC Evidence={ECO:0000250|UniProtKB:P49961}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64881; CC Evidence={ECO:0000250|UniProtKB:P49961}; CC -!- CATALYTIC ACTIVITY: CC Reaction=GTP + 2 H2O = GMP + 2 H(+) + 2 phosphate; CC Xref=Rhea:RHEA:64904, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58115; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64905; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=GDP + H2O = GMP + H(+) + phosphate; Xref=Rhea:RHEA:22156, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:58115, ChEBI:CHEBI:58189; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22157; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2 H2O + ITP = 2 H(+) + IMP + 2 phosphate; CC Xref=Rhea:RHEA:77735, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:58053, ChEBI:CHEBI:61402; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77736; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + ITP = H(+) + IDP + phosphate; Xref=Rhea:RHEA:28330, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:58280, ChEBI:CHEBI:61402; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28331; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + IDP = H(+) + IMP + phosphate; Xref=Rhea:RHEA:35207, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:58053, ChEBI:CHEBI:58280; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35208; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2 H2O + UTP = 2 H(+) + 2 phosphate + UMP; CC Xref=Rhea:RHEA:64896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:46398, ChEBI:CHEBI:57865; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64897; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + UTP = H(+) + phosphate + UDP; Xref=Rhea:RHEA:64900, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:46398, ChEBI:CHEBI:58223; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64901; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + UDP = H(+) + phosphate + UMP; Xref=Rhea:RHEA:64876, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, CC ChEBI:CHEBI:57865, ChEBI:CHEBI:58223; CC Evidence={ECO:0000269|PubMed:22100451}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:64877; CC Evidence={ECO:0000269|PubMed:22100451}; CC -!- COFACTOR: CC Name=Ca(2+); Xref=ChEBI:CHEBI:29108; CC Evidence={ECO:0000269|PubMed:9221928}; CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:9221928}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=4.7 uM for ADP {ECO:0000269|PubMed:22100451}; CC KM=10 uM for UTP {ECO:0000269|PubMed:22100451}; CC KM=11.3 uM for UDP {ECO:0000269|PubMed:22100451}; CC KM=9 uM for GTP {ECO:0000269|PubMed:22100451}; CC KM=11.4 uM for GDP {ECO:0000269|PubMed:22100451}; CC KM=48.8 uM for GDP (with 100 uM AMP) {ECO:0000269|PubMed:22100451}; CC KM=13.1 uM for GDP (with 100 uM UMP) {ECO:0000269|PubMed:22100451}; CC KM=149 uM for GDP (with 100 muM hexaammonium heptamolybdate CC tetrahydrate) {ECO:0000269|PubMed:22100451}; CC KM=10.8 uM for ITP {ECO:0000269|PubMed:22100451}; CC KM=10.5 uM for IDP {ECO:0000269|PubMed:22100451}; CC KM=749.5 uM for thiamine(1+) diphosphate CC {ECO:0000269|PubMed:22100451}; CC -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000250|UniProtKB:Q9MYU4}. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250|UniProtKB:P49961}; Multi- CC pass membrane protein {ECO:0000250|UniProtKB:P49961}. Membrane, caveola CC {ECO:0000250|UniProtKB:P49961}. CC -!- TISSUE SPECIFICITY: Expressed in primary neurons and astrocytes, CC kidney, liver, muscle, thymus, lung and spleen. CC {ECO:0000269|PubMed:9221928}. CC -!- PTM: N-glycosylated. {ECO:0000269|PubMed:9221928}. CC -!- PTM: The N-terminus is blocked. {ECO:0000250|UniProtKB:P49961}. CC -!- PTM: Palmitoylated on Cys-13; which is required for caveola targeting. CC {ECO:0000250|UniProtKB:P49961}. CC -!- SIMILARITY: Belongs to the GDA1/CD39 NTPase family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U81295; AAC53195.1; -; mRNA. DR EMBL; Y15685; CAA75730.1; -; mRNA. DR PDB; 3ZX0; X-ray; 2.50 A; A/B/C/D=38-189, A/B/C/D=207-477. DR PDB; 3ZX2; X-ray; 1.81 A; A/B/C/D=38-189, A/B/C/D=207-477. DR PDB; 3ZX3; X-ray; 1.70 A; A/B/C/D=38-189, A/B/C/D=207-477. DR PDBsum; 3ZX0; -. DR PDBsum; 3ZX2; -. DR PDBsum; 3ZX3; -. DR AlphaFoldDB; P97687; -. DR SMR; P97687; -. DR STRING; 10116.ENSRNOP00000051602; -. DR BindingDB; P97687; -. DR ChEMBL; CHEMBL2767; -. DR GuidetoPHARMACOLOGY; 2888; -. DR GlyCosmos; P97687; 7 sites, No reported glycans. DR GlyGen; P97687; 7 sites. DR iPTMnet; P97687; -. DR PhosphoSitePlus; P97687; -. DR SwissPalm; P97687; -. DR PaxDb; 10116-ENSRNOP00000051602; -. DR AGR; RGD:69265; -. DR RGD; 69265; Entpd1. DR eggNOG; KOG1386; Eukaryota. DR InParanoid; P97687; -. DR PhylomeDB; P97687; -. DR BRENDA; 3.6.1.5; 5301. DR BRENDA; 3.6.1.6; 5301. DR Reactome; R-RNO-8850843; Phosphate bond hydrolysis by NTPDase proteins. DR SABIO-RK; P97687; -. DR PRO; PR:P97687; -. DR Proteomes; UP000002494; Unplaced. DR GO; GO:0005604; C:basement membrane; ISO:RGD. DR GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD. DR GO; GO:0005901; C:caveola; ISS:UniProtKB. DR GO; GO:0009986; C:cell surface; IDA:RGD. DR GO; GO:0009897; C:external side of plasma membrane; ISO:RGD. DR GO; GO:0005615; C:extracellular space; IDA:RGD. DR GO; GO:0043025; C:neuronal cell body; IDA:RGD. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0097060; C:synaptic membrane; IDA:RGD. DR GO; GO:0008021; C:synaptic vesicle; IDA:RGD. DR GO; GO:0043262; F:ADP phosphatase activity; IDA:RGD. DR GO; GO:0004050; F:apyrase activity; IEA:UniProtKB-EC. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0016887; F:ATP hydrolysis activity; IDA:RGD. DR GO; GO:0036384; F:CDP phosphatase activity; IEA:RHEA. DR GO; GO:0043273; F:CTPase activity; IEA:RHEA. DR GO; GO:0004382; F:GDP phosphatase activity; IBA:GO_Central. DR GO; GO:0003924; F:GTPase activity; IEA:RHEA. DR GO; GO:0042802; F:identical protein binding; IPI:RGD. DR GO; GO:1990003; F:IDP phosphatase activity; IEA:RHEA. DR GO; GO:0103023; F:ITPase activity; IEA:RHEA. DR GO; GO:0017110; F:nucleoside diphosphate phosphatase activity; IDA:UniProtKB. DR GO; GO:0017111; F:ribonucleoside triphosphate phosphatase activity; IDA:UniProtKB. DR GO; GO:0045134; F:UDP phosphatase activity; IBA:GO_Central. DR GO; GO:0046032; P:ADP catabolic process; ISO:RGD. DR GO; GO:0071275; P:cellular response to aluminum ion; IEP:RGD. DR GO; GO:0035457; P:cellular response to interferon-alpha; IEP:RGD. DR GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD. DR GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISO:RGD. DR GO; GO:2001170; P:negative regulation of ATP biosynthetic process; IMP:RGD. DR GO; GO:0033602; P:negative regulation of dopamine secretion; IMP:RGD. DR GO; GO:0009134; P:nucleoside diphosphate catabolic process; IBA:GO_Central. DR GO; GO:0030168; P:platelet activation; ISO:RGD. DR GO; GO:0070527; P:platelet aggregation; ISS:UniProtKB. DR GO; GO:0009181; P:purine ribonucleoside diphosphate catabolic process; ISO:RGD. DR GO; GO:0033198; P:response to ATP; IEP:RGD. DR GO; GO:0010996; P:response to auditory stimulus; IEP:RGD. DR GO; GO:0031000; P:response to caffeine; IEP:RGD. DR GO; GO:0010332; P:response to gamma radiation; IEP:RGD. DR GO; GO:1903576; P:response to L-arginine; IEP:RGD. DR GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD. DR GO; GO:0010238; P:response to proline; IEP:RGD. DR CDD; cd00012; NBD_sugar-kinase_HSP70_actin; 1. DR Gene3D; 3.30.420.40; -; 1. DR Gene3D; 3.30.420.150; Exopolyphosphatase. Domain 2; 1. DR InterPro; IPR000407; GDA1_CD39_NTPase. DR PANTHER; PTHR11782; ADENOSINE/GUANOSINE DIPHOSPHATASE; 1. DR PANTHER; PTHR11782:SF32; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; 1. DR Pfam; PF01150; GDA1_CD39; 1. DR PROSITE; PS01238; GDA1_CD39_NTPASE; 1. PE 1: Evidence at protein level; KW 3D-structure; ATP-binding; Calcium; Disulfide bond; Glycoprotein; KW Hydrolase; Magnesium; Membrane; Nucleotide-binding; Reference proteome; KW Transmembrane; Transmembrane helix. FT CHAIN 1..511 FT /note="Ectonucleoside triphosphate diphosphohydrolase 1" FT /id="PRO_0000209904" FT TOPO_DOM 1..16 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 17..37 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 38..478 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 479..499 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 500..511 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT REGION 46..171 FT /note="N-terminal lobe" FT REGION 205..441 FT /note="C-terminal lobe" FT ACT_SITE 174 FT /note="Proton acceptor" FT /evidence="ECO:0000250|UniProtKB:O35795" FT CARBOHYD 73 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 226 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 291 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 333 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 374 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 429 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 458 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 84..108 FT /evidence="ECO:0000269|PubMed:22100451" FT DISULFID 254..300 FT /evidence="ECO:0000269|PubMed:22100451" FT DISULFID 281..324 FT /evidence="ECO:0000269|PubMed:22100451" FT DISULFID 337..342 FT /evidence="ECO:0000269|PubMed:22100451" FT DISULFID 391..414 FT /evidence="ECO:0000269|PubMed:22100451" FT STRAND 47..55 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 60..68 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 79..85 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 87..89 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 91..94 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 98..100 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 101..115 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 118..121 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 125..130 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 132..140 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 142..157 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 159..168 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 171..185 FT /evidence="ECO:0007829|PDB:3ZX3" FT TURN 186..189 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 209..213 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 215..222 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 229..231 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 232..234 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 235..240 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 243..253 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 257..268 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 273..279 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 287..291 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 292..295 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 299..304 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 311..317 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 321..329 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 338..344 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 356..360 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 361..372 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 380..391 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 395..401 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 407..410 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 413..425 FT /evidence="ECO:0007829|PDB:3ZX3" FT HELIX 432..437 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 438..440 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 442..444 FT /evidence="ECO:0007829|PDB:3ZX3" FT STRAND 447..451 FT /evidence="ECO:0007829|PDB:3ZX2" FT HELIX 452..459 FT /evidence="ECO:0007829|PDB:3ZX3" SQ SEQUENCE 511 AA; 57408 MW; 4CC123D3E644C193 CRC64; MEDIKDSKVK RFCSKNILII LGFSSVLAVI ALIAVGLTHN KPLPENVKYG IVLDAGSSHT NLYIYKWPAE KENDTGVVQL LEECQVKGPG ISKYAQKTDE IAAYLAECMK MSTERIPASK QHQTPVYLGA TAGMRLLRME SKQSADEVLA AVSRSLKSYP FDFQGAKIIT GQEEGAYGWI TINYLLGRFT QEQSWLNFIS DSQKQATFGA LDLGGSSTQV TFVPLNQTLE APETSLQFRL YGTDYTVYTH SFLCYGKDQA LWQKLAQDIQ VSSGGILKDP CFYPGYKKVV NVSELYGTPC TKRFEKKLPF NQFQVQGTGD YEQCHQSILK FFNNSHCPYS QCAFNGVFLP PLQGSFGAFS AFYFVMDFFK KMANDSVSSQ EKMTEITKNF CSKPWEEVKA SYPTVKEKYL SEYCFSGTYI LSLLLQGYNF TGTSWDQIHF MGKIKDSNAG WTLGYMLNLT NMIPAEQPLS PPLPHSTYIS LMVLFSLVLV AMVITGLFIF SKPSYFWKEA V //